Oversea-Chinese Banking Corp (OCBC)’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-34,125
Closed -$1.52M – 391
2024
Q4
$1.52M Buy
34,125
+16,365
+92% +$918K 0.04% 197
2024
Q3
$1.05M Buy
17,760
+1,745
+11% +$102K 0.03% 234
2024
Q2
$971K Buy
16,015
+11,873
+287% +$743K 0.03% 221
2024
Q1
$329K Sell
4,142
-80
-2% -$6.11K 0.01% 312
2023
Q4
$333K Sell
4,222
-3,848
-48% -$274K 0.01% 268
2023
Q3
$563K Buy
8,070
+1,111
+16% +$78.7K 0.03% 243
2023
Q2
$481K Sell
6,959
-1,449
-17% -$103K 0.02% 226
2023
Q1
$626K Buy
8,408
+861
+11% +$72.2K 0.03% 205
2022
Q4
$703K Buy
+7,547
New +$728K 0.04% 189

Other funds holding CVS

Oversea-Chinese Banking Corp (OCBC)'s CVS Position: Q1 2025 in Review

Oversea-Chinese Banking Corp (OCBC) sold out of CVS Health (CVS) in Q1 2025, closing a stake of 34,125 shares — an estimated $1.52M sold.

Oversea-Chinese Banking Corp (OCBC) first reported a position in CVS in Q4 2022 and held it in 9 quarters. The position peaked at $1.52M in Q4 2024. 1,757 funds tracked by Wall St. Rank hold CVS as of Q1 2025.

  • Oversea-Chinese Banking Corp (OCBC) reported no remaining CVS Health position as of Q1 2025 after selling out during the quarter.
  • Oversea-Chinese Banking Corp (OCBC) sold 34,125 CVS Health shares in Q1 2025, an estimated $1.52M.
  • Oversea-Chinese Banking Corp (OCBC) first reported a position in CVS Health in Q4 2022 and held it in 9 quarters.
  • Oversea-Chinese Banking Corp (OCBC)'s CVS Health position peaked at $1.52M in Q4 2024.
  • 1,757 funds tracked by Wall St. Rank held CVS Health as of Q1 2025.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q1 2025, filed 2 May 2025.